Corrected Race Infringement Car 81 Causing A Collision With Car 12 In Turn 1
São Paulo Grand Prix · 2025 · 9 November 2025 · Doc 68
- Driver
- Oscar Piastri
- Team
- McLaren Formula 1 Team
- Session
- Race
2025 SÃO PAULO GRAND PRIX
07 - 09 November 2025
From The Stewards
To The Team Manager,
McLaren Formula 1 Team Document 68 Date 09 November 2025 Time 18:34
The Stewards, having received a report from the Race Director, have considered the following matter and determine the following:
No / Driver 81 - Oscar Piastri Competitor McLaren Formula 1 Team Time 14:12
Session Race
Fact Car 81 collided with Car 12 in Turn 1. Infringement Breach of Appendix L, Chapter IV, Article 2 d) of the FIA International Sporting Code. Decision 10 second time penalty. 2 penalty points (total of 6 for the 12 month period). Reason The Stewards reviewed video and in-car video evidence.
At the Safety Car restart on Lap 6, Car 81 (Oscar Piastri) attempted to overtake Car 12 (Kimi Antonelli) on the inside of Turn 1. In doing so, PIA did not establish the required overlap prior to and at the apex, as his front axle was not alongside the mirror of Car 12, as defined in the Driving Standard Guidelines for overtaking on the inside of a corner.
PIA locked the brakes as he attempted to avoid contact by slowing, but was unable to do so and made contact with ANT. This contact caused ANT to make secondary contact with Car 16 (Charles Leclerc), who was positioned on the outside and was forced to retire from the race as a result.
PIA was therefore wholly responsible for the collision. A 10-second time penalty and 2 penalty points are considered appropriate and consistent with recent precedents. Competitors are reminded that they have the right to appeal certain decisions of the Stewards, in accordance with Article 15 of the FIA International Sporting Code and Chapter 4 of the FIA Judicial and Disciplinary Rules, within the applicable time limits. Decisions of the Stewards are taken independently of the FIA and are based solely on the relevant regulations, guidelines and evidence presented.